Among probands tested within or outside of SMA Identified, the SMN2 c.859G>C variant was observed in 0.8% of individuals (n = 11/1,345) with a positive SMA molecular diagnosis. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.